Status:
COMPLETED
Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)
Lead Sponsor:
Momentum Data
Collaborating Sponsors:
Pfizer
Oxford Royal College of General Practitioners Research and Surveillance Centre
Conditions:
Atopic Dermatitis Eczema
Atopic Dermatitis
Eligibility:
All Genders
Brief Summary
Atopic dermatitis (AD), commonly called eczema, is one of the most frequently occurring skin conditions. It is estimated to affect around one fifth of children in developed countries and is also becom...
Detailed Description
Objective The study aims to describe the health care resource utilisation of patients with active AD in terms of prescription use, primary care appointments, and specialist referrals. Method This st...
Eligibility Criteria
Inclusion
- All paediatric and adult patients registered with an Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) contributing GP practice during the study period (2008-2018) and with at least one year of follow-up.
Exclusion
- The presence of psoriasis, photodermatitis, or ichthyosis
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 4 2020
Estimated Enrollment :
148166 Patients enrolled
Trial Details
Trial ID
NCT03823794
Start Date
February 1 2019
End Date
November 4 2020
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Momentum Data Ltd
London, United Kingdom, WC1X 8QT